Jonathan Drake, MD
Neurology · Providence, RINPI 1891132924
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,050 of the $1,325 with a category attached, or 79.3%. Every reported general payment came from a single manufacturer, Eisai Inc..
Across 10 payments — averaging $132.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$1K
Across 127 payments — averaging $23,608 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$1.5M
- Eisai Inc.$1.4M
- Biohaven Pharmaceutical Holding Company Ltd.$8K
- Biohaven Pharmaceuticals, Inc.$3K
What the payments were for
- Travel & lodging$1,05079%
- Food & beverage$27521%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 10 | $1,325 |
How this compares
$1,325 in reported general payments places this provider in the 60th percentile of 86 neurology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rivastigmine | 102 | $20,617 |
| Memantine Hcl | 402 | $15,059 |
| Galantamine ErGalantamine Hbr | 74 | $6,619 |
| Donepezil Hcl | 238 | $2,311 |
| RivastigmineRivastigmine Tartrate | 11 | $1,195 |
| Trazodone Hcl | 95 | $960 |
| Citalopram HbrCitalopram Hydrobromide | 70 | $692 |
| Quetiapine Fumarate | 37 | $455 |
| Sertraline Hcl | 46 | $362 |
| Levetiracetam | 12 | $266 |
Paid to pharmacies, not to this prescriber.
Other neurology in Providence
- Stephen SallowayProvidence$329K
- Syed RizviProvidence$160K
- John EastonProvidence$112K
- Saima ChaudhryProvidence$90K
- Monica DhakarProvidence$45K
- Jeffrey WishikProvidence$34K
- Prathana PrakashProvidence$31K
- Karen FurieProvidence$29K
- Chuang WuProvidence$14K
- Emily WeisbachProvidence$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.